Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (451-460 of 519) with videos related to

Pageof 52
Sort By:
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Journal of Extracellular Vesicles|April 14, 2021
Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platformsTanina Arab, Emily R Mallick, Yiyao Huang, et al.
The Journal of Clinical Investigation|March 26, 2011
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowYusuke Shiozawa, Elisabeth A Pedersen, Aaron M Havens, et al.
The Prostate|September 1, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.
The Prostate|May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancerRudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
Genome Research|December 15, 2010
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumorsChristiane M Robbins, Waibov A Tembe, Angela Baker, et al.
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
Cancer Research|May 17, 2012
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasisSerk In Park, Jinhui Liao, Janice E Berry, et al.
Pageof 52

Showing results (451-460 of 519) with videos related to

Sort By:
Pageof 52
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
Investigational New Drugs|March 26, 2010
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortiumDeborah A Bradley, Stephanie Daignault, Charles J Ryan, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Journal of Extracellular Vesicles|April 14, 2021
Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single-particle analysis platformsTanina Arab, Emily R Mallick, Yiyao Huang, et al.
The Journal of Clinical Investigation|March 26, 2011
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowYusuke Shiozawa, Elisabeth A Pedersen, Aaron M Havens, et al.
The Prostate|September 1, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.
The Prostate|May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancerRudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
Genome Research|December 15, 2010
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumorsChristiane M Robbins, Waibov A Tembe, Angela Baker, et al.
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
Cancer Research|May 17, 2012
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasisSerk In Park, Jinhui Liao, Janice E Berry, et al.
Pageof 52